| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6100739 | Journal of Crohn's and Colitis | 2010 | 5 Pages |
Abstract
There appears to be a subset of IBD patients with perianal and more distant inflammatory dermatoses, who benefit from high dose vitamin B12 treatment. Clinical trials in IBD patients with biopsy-characterised suppurative dermatoses will be required in order to properly define the role of this safe and economical therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Marianne Mortimore, Timothy H.J. Florin,